• LAST PRICE
    2.3700
  • TODAY'S CHANGE (%)
    Trending Down-0.1200 (-4.8193%)
  • Bid / Lots
    2.2700/ 1
  • Ask / Lots
    2.7300/ 43
  • Open / Previous Close
    2.4900 / 2.4900
  • Day Range
    Low 2.2700
    High 2.5000
  • 52 Week Range
    Low 1.6850
    High 8.8300
  • Volume
    1,829,146
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Oct 2, 2024

      Show headlines and story abstract
    • 4:01PM ET on Wednesday Oct 02, 2024 by Dow Jones
      Companies Mentioned: FATE

      Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

      SAN DIEGO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on October 1, 2024 the Company granted restricted stock units (RSUs) representing 16,400 shares of its common stock to two newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company's Board of Directors and granted under the Company's Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.

Peers Headlines